retatrutide clinical trial results Results: 28.3% Weight Loss Data Triple hormone receptor agonist retatrutide

Semaglutide and similar compounds do not directly damage kidney tissue, but they can influence hydration status and blood pressureboth factors that impact remaining kidney health

In a meta-analysis with patients with T1D, weight loss with liraglutide 1.8 mg was estimated at ~5 kg compared to placebo (62), and there was a dose-response effect

Notably, there is a clear inverse relationship between the degree of food processing and the monetary cost per calorie, making highly processed foods, typically rich in fats and sugars, far more accessible to the general population (Ravandi et al., 2025)

[DOI] [PMC free article] [PubMed] [Google Scholar] 635